RE FRANCESCA

Kravicz, M., Taiarol, L., Viegas, J., Sierri, G., Mauri, M., Koch, M., et al. (2024). Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 101(Part A November 2024) [10.1016/j.jddst.2024.106238]. Detail

Pagnacco, C., Kravicz, M., Sica, F., Fontanini, V., González de San Román, E., Lund, R., et al. (2024). In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions. BIOMACROMOLECULES, 25(6), 3583-3595 [10.1021/acs.biomac.4c00210]. Detail

Rivara, M., Nicolini, G., Malacrida, A., Re, F., Incerti, M., Russo, G., et al. (2024). New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma. RESULTS IN CHEMISTRY, 9(July 2024) [10.1016/j.rechem.2024.101645]. Detail

Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Detail

Viale, F., Ciprandi, M., Leoni, L., Sierri, G., Renda, A., Barbugian, F., et al. (2024). Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 96(June 2024) [10.1016/j.jddst.2024.105672]. Detail